The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Zimovane 7.5 mg Film-coated Tablets

Mylan IRE Healthcare LimitedPA2010/057/001

Main Information

Trade NameZimovane 7.5 mg Film-coated Tablets
Active SubstancesZopiclone
Dosage FormFilm-coated tablet
Licence HolderMylan IRE Healthcare Limited
Licence NumberPA2010/057/001

Group Information

ATC CodeN05CF Benzodiazepine related drugs
N05CF01 zopiclone


License statusAuthorised
Licence Issued18/08/2006
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceThis product contains a substance listed in schedule 4, part 1 to the Misuse of Drugs Regulations 2017.
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0055-041-003
Interchangeable List DocumentPDF of Interchangeable List
« Back